Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Mereo BioPharma Group plc - Sponsored ADR (MREO) had Stock-Based Compensation of $7.60M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.50M |
|
$-41.88M |
|
$0.13M |
|
$0.37M |
|
$40.61M |
|
$-40.11M |
|
$-1.77M |
|
$-41.88M |
|
$-41.88M |
|
$-41.88M |
|
$-41.88M |
|
$-41.88M |
|
$-41.88M |
|
$-40.11M |
|
$-39.48M |
|
159.42M |
|
159.42M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$45.02M |
|
$0.14M |
|
$0.90M |
|
$45.92M |
|
$4.30M |
|
-- |
|
$0.70M |
|
$5.00M |
|
$40.92M |
|
$40.40M |
|
$40.92M |
|
159.13M |
|
| Cash Flow Statement Financials | |
$-30.97M |
|
$-0.02M |
|
$0.33M |
|
$69.80M |
|
$40.99M |
|
$-28.81M |
|
|
Stock-Based Compensation |
$7.60M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
73.40% |
|
-8021.40% |
|
-8021.40% |
|
-7897.00% |
|
-8375.60% |
|
-8375.60% |
|
$-30.99M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-102.35% |
|
-103.66% |
|
-91.20% |
|
-102.35% |
|
$0.26 |
|
$-0.19 |
|
$-0.19 |
|